Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice

Microbiology and Immunology

Volumn 52, Issue 2, 2008, Pages 118-127

  Ami, Yasushi ^a   Nagata, Noriyo ^a   Shirato, Kazuya ^a   Watanabe, Rie ^a   Iwata, Naoko ^a   Nakagaki, Keiko ^a   Fukushi, Shuetsu ^a   Saijo, Masayuki ^a   Morikawa, Shigeru ^a   Taguchi, Fumihiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Coronavirus; Elastase; Mouse; SARS

Indexed keywords

ELASTASE; LIPOPOLYSACCHARIDE; PANCREATIC ELASTASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME SYNTHESIS; HISTOPATHOLOGY; LUNG; MALE; MIXED INFECTION; MORTALITY; MOUSE; NONHUMAN; PASTEURELLA PNEUMOTROPICA; PNEUMONIA; RESPIRATORY TRACT DISEASE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BODY WEIGHT; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; PATHOLOGY; PATHOPHYSIOLOGY; SURVIVAL; VIROLOGY; VIRUS PNEUMONIA;

BACTERIA (MICROORGANISMS); CORONAVIRUS; MUS; SARS CORONAVIRUS;

ANIMALS; BODY WEIGHT; LUNG; MALE; MICE; MICE, INBRED BALB C; PANCREATIC ELASTASE; PASTEURELLA PNEUMOTROPICA; PNEUMONIA, VIRAL; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 51449098027     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00011.x     Document Type: Article

References (37)

1. Drosten C., Gunther S., Preiser W., Van Der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikowa L., Fouchier R.A., Berger A., Burguiere A.M., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., Doerr H.W. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Eng J Med 348: 1967-76.
2. Kuiken T., Fouchier R.A., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D., Laman J.D., de Jong T., van Doornum G., Lim W., Ling A.E., Chan P.K., Tam J.S., Zambon M.C., Gopal R., Drosten C., van der Werf S., Escriou N., Manuguerra J.C., Stohr K., Peiris J.S., Osterhaus A.D. (2003) Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263-70.
3. Peiris J.S., Guan Y., Yuen K.Y. (2005) Severe acute respiratory syndrome. Nat med 10: 588-97.
4. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., Roper R.L. (2003) The genome sequence of SARS-associated coronavirus. Science 300: 1399-404.
5. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394-9.
6. Li W., Moore M.H., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450-4.
7. Fouchier R.A., Kuiken T., Schutten M., Amerongen G.V., Van Doornum G.J., Van Den Hoogen B.G., Peiris M., Lim W., Stohr K., Osterhaus D. (2003) Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423: 240.
8. Martina B.E., Haagmans B.L., Kuiken T., Fouchier R.A., Rimmelzwaan G.F., Van Amerongen G., Peiris J.S., Lim W., Osterhaus A.D. (2003) SARS virus infection of cats and ferrets. Nature 425: 915.
9. Nagata N., Iwata N., Hasegawa H., Fukushi S., Yokoyama M., Harashima A., Sato Y., Saijo M., Morikawa S., Sata T. (2007) Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol 81: 1848-57.
10. Roberts A., Paddock C., Vogel L., Butler S., Zaki S., Subbarao K. (2005) Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol 79: 5833-8.
11. Subbarao K., McAuliffe J., Vogel L., Fahle G., Fischer S., Tatti K., Packard M., Shieh W.J., Zaki S., Murphy B. (2004) Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 78: 3572-7. 12. Weiss S.R., Navas-Martin S. (2005) Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol Biol Rev 69: 635-64.
12. McCray P.B. Jr, Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., Netland J., Jia H.P., Halabi C., Sigmund C.D., Meyerholz D.K., Kirby P., Look D.C., Perlman S. (2007) Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol 81: 813-21.
13. Tseng C.T., Huang C., Newman P., Wang N., Narayanan K., Watts D.M., Makino S., Packard M., Zaki S.R., Chan T.S., Peters C.J. (2007) SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor. J Virol 81: 1162-73.
14. Roberts A., Deming D., Paddock C., Cheng A., Yount B., Vogel L., Herman B., Sheahan T., Heise M., Genrich G., Zaki S., Baric R., Subbarao K. (2007) A Mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PloS Pathogens 3: 23-37.
15. Poutanen S.M., Low D.E., Henry B., Finkelstein S., Rose D., Green K., Tellier R., Draker R., Adachi D., Ayers M., Chan A.K., Skowronski D.M., Salit I., Simor A.E., Slutsky A.S., Doyle P.W., Krajden M., Petric M., Brunham R.C., McGeer A.J. (2003) Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348: 1995-2005.
16. Matsuyama S., Ujike M., Morikawa S., Tashiro M., Taguchi F. (2005) Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci USA 102: 12543-7.
17. Thiel V., Ivanov K.A., Putics A., Hertzig T., Schelle B., Bayer S., Weissbrich B., Snijder E.J., Rabenau H., Doerr H.W., Gorbalenya A.E., Ziebuhr J. (2003) Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol 84: 2305-15.
18. Nakagawa M., Saito M. (1984) Antigenic characterization of Pasteurella pneumotropica isolated from mice and rats. Jikken Dobutsu 30: 313-6.
19. Yoshimura K., Nakagawa S., Koyama S., Kobayashi T., Homma T. (1994) Roles of neutrophil elastase and superoxide anion in leukotriene B4-induced lung injury in rabbit. J Appl Physiol 76: 91-6.
20. Jacoby R.O., Fox J.G., Davisson M. (2002) In: Laboratory Animal Medicine. New York: Academic Press, pp. 35-120.
21. Kawabata K., Hagio T., Matsuoka S. (2002) The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 451: 1-10.
22. Nicholls J.M., Poon L.L.M., Lee K.C., Ng W.F., Lai S.T., Leung C.Y., et al (2003) Lung pathology of Fatal severe acute respiratory syndrome. Lancet 361: 1773-8.
23. Tse G.M.K., To K.F., Chan P.K.S., Lo A.W.I., Ng K.C., Wu A., et al (2004) Pulmonary pathological features in coronavirus associated acute respiratory syndrome (SARS). J. Clin. Pathol. 57: 260-5.
24. Glass W.G., Subbarao K., Murphy B., Murphy P.M. (2004) Mechanism of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol 173: 4030-9.
25. Roberts A.L., Guarner V.J., Hayes N., Murphy B., Zaki S., Subbarao K. (2005) Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol 79: 503-11.
26. Greenough T.C., Carville C.A., Coderre J., Somasundaran M., Sullivan J.L., Luzuriaga K., Manfield K. (2005) Pneumonia and multi-organ system disease in common marmosets (Callithrix jacchus) infected with severe acute respiratory syndrome-associated coronavirus. Am J Pathol 167: 455-63.
27. Qin C., Wang J., Wei Q., She M., Marasco W.A., Jiang H., Tu X., Zhu H., Ren L., Gao H., Gujo L., Huang L., Yang R., Cong Z., Wang Y., Liu Y., Sun L., Duan S., Qu J., Chen L., Tong W., Ruan L., Liu P., Zhang H., Zhang J., Liu D., Liu Q., Hong T., He W. (2005) An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol 206: 251-9.
28. Weingartl H., Czub M., Czub S., Neufeld J., Marzal P., Gren J., Smith G., Jones S, Proulx R., Deschambault Y., Brudeski E., Andonov A., He R., Li Y., Copps J., Grolla A., Dick D., Berry J., Ganske S., Manning L., Cao J. (2004) Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol 78: 12672-6.
29. Li W., Zhang C., Sui J., Kuhn J.H., Moore M.J., Luo S., Wong S.K., Huang I.C., Xu K., Vasillieva N., Murakami A., He Y., Marasco W.A., Guan Y., Choe H., Farzan M. (2005) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 24: 1634-43.
30. The Chinese S.A.R.S. Molecular E.pidemiology Consortium. (2004) Molelular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303: 1666-9.
31. Iacono K.T., Kazi L., Weiss S.R. (2006) Both spike and background genes contribute to murine coronavirus neurovirulence. J Virol 80: 6834-43.
32. Phillips J.J., Chua M.M., Lavi E., Weiss S.R. (1999) Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol 73: 7752-60.
33. Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leog-poi H., Crackower H.A., Fukamizu A., Hui C., Hein L., Uhling S., Slutsky A.S., Jiang C., Penninger J.M. (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436: 112-6.
34. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A.S., Liu D., Qin C., Jiang C., Penninger C.M. (2005) A crucial role of angiotensin converting enzyme 2 (ACE 2) in SARS coronavirus-induced lung injury. Nat Med 11: 875-9.
35. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J. (2003) A novel coronavirus associated with Severe acute respiratory syndrome. N Engl J Med 348: 1953-66.
36. Rowe T., Gao G., Hogan R.J., Crystal R.G., Voss T.G., Grant R.L., Bell P., Kobinger G.P., Wivel N.A., Wilson J.M. (2004) Macaque model for severe acute respiratory syndrome. J Virol 78: 11401-4.
37. Peiris J.S., Yuen K.Y., Osterhaus A.D., Stohr K. (2003) The severe acute respiratory syndrome. New Engl. J. Med. 349: 2431-41.